23683607 |
Efficacy and toxicity of factor Xa inhibitors
Montana, M,
Rathelot, P,
Vanelle, P,
Bondarenko, M,
Curti, C
|
J Pharm Pharm Sci |
2013 |
19297154 |
Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor
Su, T,
Bauer, SM,
Li, W,
Lambing, JL,
Woolfrey, J,
Scarborough, RM,
Wu, Y,
Arfsten, AE,
Huang, W,
Park, G,
Fan, J,
Kanter, J,
Hutchaleelaha, A,
Goldman, EA,
Probst, GD,
Hollenbach, SJ,
Zhang, P,
Jia, ZJ,
Edwards, ST,
Clizbe, LA,
Bao, L,
Zhu, BY,
Pandey, A,
Song, Y,
Sinha, U,
Wong, PW,
Wang, L
|
Bioorg. Med. Chem. Lett. |
2009 |
16161994 |
Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor
Lampe, T,
Straub, A,
Roehrig, S,
Reinemer, P,
Pohlmann, J,
Perzborn, E,
Schlemmer, KH,
Pernerstorfer, J
|
J. Med. Chem. |
2005 |